Ameren announces director resignation amid health concerns

Published 27/03/2025, 21:26
Ameren announces director resignation amid health concerns

ST. LOUIS, MO - Ameren Corporation (NYSE:AEE), a provider of electric and other services with a market capitalization of $26.64 billion, announced the immediate resignation of board member Kimberly J. Harris on March 24, 2025. Harris stepped down from her role due to personal health reasons, according to a recent 8-K filing with the Securities and Exchange Commission. According to InvestingPro data, the company maintains a FAIR financial health rating and trades at a P/E ratio of 22.27.

The company stated that Harris’s decision to leave was not related to any disagreements with Ameren’s operations, policies, or practices, but rather a choice to focus on her health and recovery following a recent medical issue.

Ameren, headquartered in St. Louis, Missouri, has not yet announced a successor for Harris’s position on the board. The departure leaves a vacancy in the company’s leadership team, which will require attention in the coming weeks.

As of now, Ameren has not provided any additional details on potential candidates to fill the board position or on any interim arrangements that may be put in place.

Investors and stakeholders of Ameren will be watching closely to see how this change may influence the company’s governance and strategic direction. The utility company, well-known in the industry, continues to serve a significant customer base with its energy services.

This news comes as part of a standard disclosure in compliance with SEC regulations, ensuring transparency in corporate governance matters. Ameren’s corporate office and principal executive offices are located at 1901 Chouteau Avenue, St. Louis, Missouri.

The information reported is based on a press release statement and reflects the company’s current state of affairs as it navigates through this unexpected change in its board of directors.

In other recent news, Ameren Corporation reported its fourth-quarter 2024 earnings, revealing a mixed performance. The company posted an earnings per share (EPS) of $0.77, which fell short of the forecasted $0.81. However, Ameren’s revenue exceeded expectations, reaching $1.94 billion against the anticipated $1.92 billion. BMO Capital Markets raised its price target for Ameren to $105, maintaining an Outperform rating, following the company’s full-year EPS of $4.63, aligning with estimates. Mizuho (NYSE:MFG) Securities also lifted Ameren’s price target to $105 from $95, citing a 20% increase in the company’s five-year capital expenditure plan. Jefferies analyst Julien Dumoulin-Smith increased Ameren’s price target to $112, maintaining a Buy rating, highlighting the company’s expanded capital expenditures and strong balance sheet. Additionally, Ameren successfully issued $750 million in senior notes due 2035, with net proceeds expected to fund general corporate purposes. These developments indicate a strategic focus on infrastructure investment and long-term growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.